144 related articles for article (PubMed ID: 21380926)
1. The effect of glucosylceramide synthase on P-glycoprotein function in K562/AO2 leukemia drug-resistance cell line.
Zhang YY; Xie KM; Yang GQ; Mu HJ; Yin Y; Zhang B; Xie P
Int J Hematol; 2011 Mar; 93(3):361-367. PubMed ID: 21380926
[TBL] [Abstract][Full Text] [Related]
2. Co-suppression of MDR1 (multidrug resistance 1) and GCS (glucosylceramide synthase) restores sensitivity to multidrug resistance breast cancer cells by RNA interference (RNAi).
Zhang X; Li J; Qiu Z; Gao P; Wu X; Zhou G
Cancer Biol Ther; 2009 Jun; 8(12):1117-21. PubMed ID: 19502811
[TBL] [Abstract][Full Text] [Related]
3. GCS induces multidrug resistance by regulating apoptosis-related genes in K562/AO2 cell line.
Liu Y; Xie KM; Yang GQ; Bai XM; Shi YP; Mu HJ; Qiao WZ; Zhang B; Xie P
Cancer Chemother Pharmacol; 2010 Aug; 66(3):433-9. PubMed ID: 19936984
[TBL] [Abstract][Full Text] [Related]
4. [Study on the correlation of GCS and MDR1 genes in inducing multidrug resistance in human K562/A02 cell line].
Yang GQ; Xie KM; Liu Y; Mu HJ; Qiao WZ; Zhang B; Xie P
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2010 Jun; 27(3):299-304. PubMed ID: 20533270
[TBL] [Abstract][Full Text] [Related]
5. Reversal of multidrug resistance by magnetic Fe3O4 nanoparticle copolymerizating daunorubicin and MDR1 shRNA expression vector in leukemia cells.
Chen BA; Mao PP; Cheng J; Gao F; Xia GH; Xu WL; Shen HL; Ding JH; Gao C; Sun Q; Chen WJ; Chen NN; Liu LJ; Li XM; Wang XM
Int J Nanomedicine; 2010 Aug; 5():437-44. PubMed ID: 20957165
[TBL] [Abstract][Full Text] [Related]
6. [NF-Îș B mediates the effect of glucosylceramide synthase on P-glycoprotein modulation in a drug-resistance leukemia cell line].
Zhang X; Xie K; Zou J; Li Y; Mu H; Zhang B; Xie P
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2014 Feb; 31(1):34-8. PubMed ID: 24510559
[TBL] [Abstract][Full Text] [Related]
7. Glucosylceramide synthase upregulates MDR1 expression in the regulation of cancer drug resistance through cSrc and beta-catenin signaling.
Liu YY; Gupta V; Patwardhan GA; Bhinge K; Zhao Y; Bao J; Mehendale H; Cabot MC; Li YT; Jazwinski SM
Mol Cancer; 2010 Jun; 9():145. PubMed ID: 20540746
[TBL] [Abstract][Full Text] [Related]
8. Glucosylceramide synthase promotes Bcl-2 expression via the ERK signaling pathway in the K562/A02 leukemia drug-resistant cell line.
Wang Q; Zou J; Zhang X; Mu H; Yin Y; Xie P
Int J Hematol; 2014 Dec; 100(6):559-66. PubMed ID: 25281403
[TBL] [Abstract][Full Text] [Related]
9. Effect of phosphatase and tensin homology deleted on chromosome 10 (PTEN) gene transfection on reversal of multidrug resistance in K562/ADM cells.
Cheng Z; Yang N; Liang W; Yan X; Li L; Pan L
Leuk Lymphoma; 2012 Jul; 53(7):1383-9. PubMed ID: 22185283
[TBL] [Abstract][Full Text] [Related]
10. Lentivirus-mediated RNA interference reversing the drug-resistance in MDR1 single-factor resistant cell line K562/MDR1.
Ye X; Liu T; Gong Y; Zheng B; Meng W; Leng Y
Leuk Res; 2009 Aug; 33(8):1114-9. PubMed ID: 19036441
[TBL] [Abstract][Full Text] [Related]
11. [Reversal of multidrug resistance by MDR1 shRNA expression vector in human leukemia K562/A02 cells].
Xiao XB; Xie ZX; Qin Q
Zhonghua Zhong Liu Za Zhi; 2006 Jun; 28(6):422-5. PubMed ID: 17152486
[TBL] [Abstract][Full Text] [Related]
12. With no interaction, knockdown of Apollon and MDR1 reverse the multidrug resistance of human chronic myelogenous leukemia K562/ADM cells.
Chen JR; Jia XH; Wang H; Yi YJ; Li YJ
Oncol Rep; 2017 May; 37(5):2735-2742. PubMed ID: 28358418
[TBL] [Abstract][Full Text] [Related]
13. Down-regulation of WT1/+17AA gene expression using RNAi and modulating leukemia cell chemotherapy resistance.
Shen H; Xu W; Wu Z; Tang H; Xie Y; Zhong X
Haematologica; 2007 Sep; 92(9):1270-2. PubMed ID: 17768125
[TBL] [Abstract][Full Text] [Related]
14. Reversion of P-glycoprotein-mediated multidrug resistance in human leukemic cell line by carnosic acid.
Yu XN; Chen XL; Li H; Li XX; Li HQ; Jin WR
Chin J Physiol; 2008 Dec; 51(6):348-56. PubMed ID: 19280878
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of glucosylceramide synthase in associated with multidrug resistance of leukemia cells.
Xie P; Shen YF; Shi YP; Ge SM; Gu ZH; Wang J; Mu HJ; Zhang B; Qiao WZ; Xie KM
Leuk Res; 2008 Mar; 32(3):475-80. PubMed ID: 17709137
[TBL] [Abstract][Full Text] [Related]
16. [siRNA silences mdr1 gene expression and reverses apoptosis resistance of K562/ADM cells line].
Wei HL; Gao LP; Jing T; Zhao HS; Yi J; Sun J; Han J
Zhonghua Xue Ye Xue Za Zhi; 2007 Jun; 28(6):388-90. PubMed ID: 17939404
[TBL] [Abstract][Full Text] [Related]
17. Tetrandrine prevents acquired drug resistance of K562 cells through inhibition of mdr1 gene transcription.
Shen H; Xu W; Chen Q; Wu Z; Tang H; Wang F
J Cancer Res Clin Oncol; 2010 May; 136(5):659-65. PubMed ID: 19898868
[TBL] [Abstract][Full Text] [Related]
18. Reversal of multi-drug resistance by pSUPER-shRNA-mdr1 in vivo and in vitro.
Pan GD; Yang JQ; Yan LN; Chu GP; Liu Q; Xiao Y; Yuan L
World J Gastroenterol; 2009 Jan; 15(4):431-40. PubMed ID: 19152447
[TBL] [Abstract][Full Text] [Related]
19. Effects of imatinib and 5-bromotetrandrine on the reversal of multidrug resistance of the K562/A02 cell line.
Chen BA; Shan XY; Chen J; Xia GH; Xu WL; Schmit M
Chin J Cancer; 2010 Jun; 29(6):591-5. PubMed ID: 20507731
[TBL] [Abstract][Full Text] [Related]
20. [Effect of glucosylceramide synthase on P-gp expression by ERK signal transduction pathway in leukemia multi-drug resistance cell line].
Li YL; Xie KM; Zhang YY; Mu HJ; Zhang B; Zou J; Xie P
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2012 Jun; 29(3):270-4. PubMed ID: 22678786
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]